Adalimumab News

Companies

Biocon says first set of biosimilars to hit European market by early 2018

The firm, along with Mylan NV, is developing four biosimilars: pegfilgrastim, trastuzumab, adalimumab and insulin glargine

2 min read22 Oct 2016
Companies

Two Biocon biosimilar drugs enter global clinical trials

Pegfilgrastim, used to treat cancer, and adalimumab, used to treat rheumatoid arthritis, entered phase 3 clinical trials, which entail testing on patients

2 min read8 May 2015
Companies

Cadila launches first cheaper copy of arthritis drug

The drug will be marketed under the brand name Exemptia

2 min read9 Dec 2014

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles